{"id":354209,"date":"2025-08-28T11:45:17","date_gmt":"2025-08-28T11:45:17","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-rhythm-pharmaceuticals\/"},"modified":"2025-08-28T11:45:17","modified_gmt":"2025-08-28T11:45:17","slug":"how-to-buy-rhythm-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/","title":{"rendered":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354209","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Rhythm Pharmaceuticals, Inc. (RYTM) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. Bu yenilik\u00e7i biyofarmas\u00f6tik \u015firketine yat\u0131r\u0131m yapmak i\u00e7in g\u00fcncel hisse performans\u0131n\u0131, fiyat tahminlerini ve stratejik i\u00e7g\u00f6r\u00fcleri ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Rhythm Pharmaceuticals, Inc. (RYTM) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. Bu yenilik\u00e7i biyofarmas\u00f6tik \u015firketine yat\u0131r\u0131m yapmak i\u00e7in g\u00fcncel hisse performans\u0131n\u0131, fiyat tahminlerini ve stratejik i\u00e7g\u00f6r\u00fcleri ke\u015ffedin."},"intro":"Kesin genetik obezite tedavileriyle hayatlar\u0131 ger\u00e7ekten de\u011fi\u015ftiren bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Rhythm Pharmaceuticals sadece ba\u015fka bir biyotek hisse senedi de\u011fil\u2014patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeline sahip bir hassas t\u0131p \u00f6nc\u00fcs\u00fcd\u00fcr. Geleneksel sekt\u00f6rlerin \u00f6tesine bakan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in RYTM, son FDA at\u0131l\u0131mlar\u0131yla b\u00fcy\u00fck momentum yaratan y\u00fcksek b\u00fcy\u00fcme nadir hastal\u0131k pazar\u0131na b\u00fcy\u00fcleyici bir giri\u015f noktas\u0131 sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kesin genetik obezite tedavileriyle hayatlar\u0131 ger\u00e7ekten de\u011fi\u015ftiren bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Rhythm Pharmaceuticals sadece ba\u015fka bir biyotek hisse senedi de\u011fil\u2014patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeline sahip bir hassas t\u0131p \u00f6nc\u00fcs\u00fcd\u00fcr. Geleneksel sekt\u00f6rlerin \u00f6tesine bakan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in RYTM, son FDA at\u0131l\u0131mlar\u0131yla b\u00fcy\u00fck momentum yaratan y\u00fcksek b\u00fcy\u00fcme nadir hastal\u0131k pazar\u0131na b\u00fcy\u00fcleyici bir giri\u015f noktas\u0131 sunuyor."},"body_html":"<h2>\ud83d\udcc8 RYTM Hisse Analizi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, Rhythm Pharmaceuticals, Inc. (RYTM) hisseleri <strong>99,20 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak takviminize not edin\u2014<strong>4 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz olacak. O g\u00fcn Rhythm \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve tarih tekerr\u00fcr ederse, bu ba\u015fka bir patlay\u0131c\u0131 an olabilir.<\/p> <h3>FDA Haberleri RYTM Hisselerini Nas\u0131l Hareket Ettiriyor<\/h3> <p>Desen a\u00e7\u0131k: d\u00fczenleyici haberler fiyat hareketi demek. Rhythm, setmelanotid i\u00e7in sNDA'n\u0131n FDA taraf\u0131ndan kabul edildi\u011fini <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/20\/3136704\/0\/en\/Rhythm-Pharmaceuticals-Announces-FDA-Acceptance-of-sNDA-for-Setmelanotide-in-Acquired-Hypothalamic-Obesity.html\">20 A\u011fustos 2025<\/a> tarihinde duyurdu\u011funda, hisse fiyat\u0131 birka\u00e7 g\u00fcn i\u00e7inde 98,70 $'dan 103,27 $'a y\u00fckseldi\u2014%4,6 art\u0131\u015f.<\/p> <p>\u0130\u015fte son d\u00f6n\u00fcm noktalar\u0131n\u0131n fiyat \u00fczerindeki etkileri:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Etkisi<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>20 A\u011fu 2025<\/td><td>FDA sNDA Kabul\u00fc<\/td><td>+%4,6<\/td><td>2 g\u00fcn<\/td><\/tr> <tr><td>9 Tem 2025<\/td><td>Bivamelagon Faz 2 Sonu\u00e7lar\u0131<\/td><td>+%25,4<\/td><td>1 hafta<\/td><\/tr> <tr><td>10 Tem 2025<\/td><td>175 Milyon $ Halka Arz<\/td><td>-%3,2<\/td><td>1 g\u00fcn<\/td><\/tr> <tr><td>2025 2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>Ticari Gelir \u00dcst\u00fc<\/td><td>+%8,1<\/td><td>3 g\u00fcn<\/td><\/tr> <\/tbody> <\/table> <p>Ders? FDA kataliz\u00f6rleri an\u0131nda momentum yarat\u0131rken, seyrelme olaylar\u0131 k\u0131sa vadeli d\u00fc\u015f\u00fc\u015flere neden olur ve genellikle al\u0131m f\u0131rsatlar\u0131 sunar.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: 55 $'dan 100+ $'a<\/h3> <p>Rhythm hisseleri, <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RYTM\/chart\/\">MarketBeat verilerine<\/a> g\u00f6re y\u0131lba\u015f\u0131ndan bu yana inan\u0131lmaz bir <strong>%82,74<\/strong> getiri sa\u011flad\u0131. \u0130\u015fte ayl\u0131k da\u011f\u0131l\u0131m:<\/p> <p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 55 $ (k\u0131\u015f konsolidasyon sonras\u0131)<br\/> <strong>May\u0131s 2025<\/strong>: 75-80 $ (Faz 2 deneme beklentisi)<br\/> <strong>Temmuz 2025<\/strong>: 85+ $ (deneme sonu\u00e7lar\u0131 ve halka arz)<br\/> <strong>A\u011fustos 2025<\/strong>: 99-103 $ (FDA kataliz\u00f6r zirvesi)<\/p> <p>Bu y\u00fckseli\u015fi tetikleyenler? Bivamelagon ile %9,3'e varan BMI d\u00fc\u015f\u00fc\u015f\u00fc g\u00f6steren patlay\u0131c\u0131 klinik deneme sonu\u00e7lar\u0131 ve Aral\u0131k 2025 i\u00e7in kritik FDA \u00f6ncelikli inceleme atamas\u0131.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli (\u00d6n\u00fcm\u00fczdeki 3-6 Ay)<\/h3> <p>20 Aral\u0131k 2025 PDUFA tarihi yakla\u015f\u0131rken, analistler onay verilirse RYTM'nin <strong>110-120 $<\/strong> aral\u0131\u011f\u0131na ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor. Mevcut 12 ayl\u0131k ortalama hedef fiyat <a href=\"https:\/\/valueinvesting.io\/RYTM\/estimates\">18 analiste g\u00f6re<\/a> <strong>80,83 $<\/strong>, ancak bu son momentum g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda temkinli g\u00f6r\u00fcn\u00fcyor.<\/p> <p><strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL - FDA kataliz\u00f6r penceresi ola\u011fan\u00fcst\u00fc yukar\u0131 potansiyel yarat\u0131yor.<\/p> <h3>Orta Vadeli (2026)<\/h3> <p>Ticari geni\u015flemenin h\u0131zlanmas\u0131yla <strong>130-150 $<\/strong> aral\u0131\u011f\u0131 bekleniyor. Gelirin gelecek y\u0131l %65,62 art\u0131\u015fla 310 milyon $'a ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor ve bivamelagon ba\u015far\u0131l\u0131 \u015fekilde Faz III'e ge\u00e7erse de\u011ferleme \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fleyebilir.<\/p> <h3>Uzun Vadeli (2028-2030)<\/h3> <p>2028 itibar\u0131yla birden fazla onayl\u0131 endikasyon ve uluslararas\u0131 geni\u015fleme ile <strong>200-250 $<\/strong> ula\u015f\u0131labilir g\u00f6r\u00fcn\u00fcyor. 2030'da Rhythm MC4R tedavi \u015firketi olarak hakim konuma gelirse, nadir obezite hastal\u0131klar\u0131ndaki adreslenebilir pazar g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda <strong>300+ $<\/strong> ger\u00e7ek\u00e7i.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <h3>Y\u00fcksek Etkili Riskler<\/h3> <p><strong>D\u00fczenleyici Reddetme<\/strong>: Aral\u0131k FDA karar\u0131 ikili\u2014onay hisseleri u\u00e7urur, reddedilirse %30-50 d\u00fc\u015f\u00fc\u015f olabilir.<\/p> <p><strong>Klinik Geri Ad\u0131mlar<\/strong>: Bivamelagon i\u00e7in Faz III denemeleri yak\u0131nda ba\u015flayacak\u2014herhangi bir g\u00fcvenlik sorunu y\u0131k\u0131c\u0131 olur.<\/p> <p><strong>Nakit Yak\u0131m\u0131<\/strong>: 175 milyon $ toplamas\u0131na ra\u011fmen Rhythm y\u0131lda ~188 milyon $ yak\u0131yor. 12-18 ay i\u00e7inde ek finansman gerekecek.<\/p> <h3>Orta Riskler<\/h3> <p><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri rakip MC4R agonistleri geli\u015ftiriyor.<\/p> <p><strong>Fiyat Bask\u0131s\u0131<\/strong>: \u00d6deme yapanlar nadir hastal\u0131k tedavilerinde y\u00fcksek fiyatlara kar\u015f\u0131 diren\u00e7 g\u00f6sterebilir.<\/p> <h2>\ud83d\udfe2 Pozitif Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanma Nedenleri<\/h2> <h3>Klinik Ba\u015far\u0131lar<\/h3> <p><a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/rhythm-stock-climbs-encouraging-obesity-data\/\">Faz 2 bivamelagon verileri<\/a> ola\u011fan\u00fcst\u00fcyd\u00fc\u2014plasebonun %2,2 art\u0131\u015f\u0131na kar\u015f\u0131l\u0131k %9,3 BMI d\u00fc\u015f\u00fc\u015f\u00fc. Bu marjinal bir iyile\u015fme de\u011fil; potansiyel olarak uygulamay\u0131 de\u011fi\u015ftiren bir geli\u015fme.<\/p> <h3>Pazar Tekeli<\/h3> <p>Orphan ila\u00e7 stat\u00fcs\u00fc 7 y\u0131l pazar tekel hakk\u0131 sa\u011fl\u0131yor\u2014b\u00fcy\u00fck bir rekabet engeli.<\/p> <h3>Gelir H\u0131zlanmas\u0131<\/h3> <p>2025 2. \u00e7eyrek %43,84 gelir art\u0131\u015f\u0131yla y\u0131ll\u0131k 187 milyon $'a ula\u015ft\u0131. B\u00fcy\u00fcme e\u011frisi dik ve s\u00fcrd\u00fcr\u00fclebilir.<\/p> <h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in \u0130\u015flem Plan\u0131<\/h2> <p><strong>Bug\u00fcn\u00fcn Ger\u00e7e\u011fi<\/strong>: RYTM ilgin\u00e7 bir noktada\u2014son zirvelerin hemen alt\u0131nda ama b\u00fcy\u00fck FDA kataliz\u00f6r\u00fc yakla\u015fmakta.<\/p> <p><strong>\u015eimdi Ne Yapmal\u0131<\/strong>:<\/p> <ol> <li><strong>Kademeli Al\u0131m Yap\u0131n<\/strong>: Hepsini birden almay\u0131n. \u015eimdi %25, 90 $'a d\u00fc\u015ferse %25, \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131ndan sonra %50 al\u0131n<\/li> <li><strong>4 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: \u00dc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131 ticari momentumun devam edip etmedi\u011fini g\u00f6sterecek<\/li> <li><strong>Aral\u0131k Volatilitesine Haz\u0131rlan\u0131n<\/strong>: FDA kararlar\u0131 a\u015f\u0131r\u0131 hareketler yarat\u0131r\u2014hem kar alma hem ortalama maliyet d\u00fc\u015f\u00fcrme planlar\u0131n\u0131z haz\u0131r olsun<\/li> <\/ol> <p><strong>Esprili Yakla\u015f\u0131m<\/strong>: \"RYTM ticareti izlemek bir t\u0131bbi drama izlemek gibi\u2014her b\u00f6l\u00fcm hastay\u0131 kurtaran ya da acil ameliyat gerektiren bir gerilimle biter. Patlam\u0131\u015f m\u0131s\u0131r\u0131n\u0131z\u0131 ve risk y\u00f6netiminizi getirin!\"<\/p> <h2>\u2705 Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu Se\u00e7in<\/td><td>NASDAQ hisselerini sunan ve makul komisyon yap\u0131s\u0131na sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014biyotek volatil olabilir<\/td><\/tr> <tr><td>3<\/td><td>\"RYTM\" Aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n\u2014volatil hisselerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Hisse miktar\u0131 ve emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option RYTM Yat\u0131r\u0131m\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor<\/h2> <p>Rhythm hikayesine ilgi duyan ama volatiliteden \u00e7ekinen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option m\u00fckemmel bir deneme alan\u0131 sunuyor. <strong>sadece 5 $ minimum depozito<\/strong> ile portf\u00f6y\u00fcn\u00fcz\u00fc a\u015f\u0131r\u0131 riske atmadan k\u00fc\u00e7\u00fck pozisyon alabilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde, biyotek hisselerinde saatlerin \u00f6nemli oldu\u011fu kritik haberler kar\u015f\u0131s\u0131nda h\u0131zl\u0131 tepki verebilirsiniz.<\/p> <p>Pocket Option'\u0131 RYTM ticareti i\u00e7in farkl\u0131 k\u0131lanlar:<\/p> <ul> <li><strong>Par\u00e7al\u0131 Hisseler<\/strong>: \u0130lk pozisyonunuz i\u00e7in 99 $ \u00e7ok y\u00fcksekse k\u0131smi hisse alabilirsiniz<\/li> <li><strong>Ger\u00e7ek Zamanl\u0131 Uyar\u0131lar<\/strong>: FDA haberleri ve kazan\u00e7lar hakk\u0131nda an\u0131nda bildirim al\u0131n<\/li> <li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong>: FDA y\u00fckseli\u015finden kar etti\u011finizde paran\u0131za kripto, e-c\u00fczdan veya geleneksel bankac\u0131l\u0131k yoluyla eri\u015fin<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Rhythm Pharmaceuticals: Nadir Hastal\u0131k Lideri<\/h2> <p>Rhythm, klinik a\u015fama \u015firketinden genetik obezite tedavilerinde ticari liderli\u011fe d\u00f6n\u00fc\u015ft\u00fc. Bayrak gemisi ilac\u0131 IMCIVREE\u00ae, POMC eksikli\u011fi ve Bardet-Biedl sendromu gibi \u00e7o\u011fu doktorun hi\u00e7 g\u00f6rmedi\u011fi \u00e7ok nadir hastal\u0131klar\u0131 tedavi ediyor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Bilgi<\/strong>: Rhythm'in ara\u015ft\u0131rmas\u0131 o kadar \u00f6zelle\u015fmi\u015f ki, d\u00fcnya \u00e7ap\u0131nda tedavilerine uygun sadece 500'\u00fcn biraz \u00fczerinde hasta i\u00e7in k\u00fcresel bir kay\u0131t tutuyorlar. Bu kitlesel pazar ila\u00e7lar\u0131 de\u011fil\u2014en \u00f6zel hassas t\u0131p \u00f6rne\u011fi.<\/p> <p>\u015eirketin yak\u0131n zamanda ger\u00e7ekle\u015ftirdi\u011fi <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/07\/10\/3113078\/0\/en\/Rhythm-Pharmaceuticals-Inc-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html\">175 milyon $'l\u0131k halka arz<\/a> 85 $ hisse fiyat\u0131yla g\u00fc\u00e7l\u00fc kurumsal g\u00fcveni g\u00f6sterdi; Morgan Stanley ve BofA Securities gibi b\u00fcy\u00fck bankalar arz\u0131 y\u00f6netti.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 RYTM Hisse Analizi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, Rhythm Pharmaceuticals, Inc. (RYTM) hisseleri <strong>99,20 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak takviminize not edin\u2014<strong>4 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz olacak. O g\u00fcn Rhythm \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve tarih tekerr\u00fcr ederse, bu ba\u015fka bir patlay\u0131c\u0131 an olabilir.<\/p>\n<h3>FDA Haberleri RYTM Hisselerini Nas\u0131l Hareket Ettiriyor<\/h3>\n<p>Desen a\u00e7\u0131k: d\u00fczenleyici haberler fiyat hareketi demek. Rhythm, setmelanotid i\u00e7in sNDA&#8217;n\u0131n FDA taraf\u0131ndan kabul edildi\u011fini <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/20\/3136704\/0\/en\/Rhythm-Pharmaceuticals-Announces-FDA-Acceptance-of-sNDA-for-Setmelanotide-in-Acquired-Hypothalamic-Obesity.html\">20 A\u011fustos 2025<\/a> tarihinde duyurdu\u011funda, hisse fiyat\u0131 birka\u00e7 g\u00fcn i\u00e7inde 98,70 $&#8217;dan 103,27 $&#8217;a y\u00fckseldi\u2014%4,6 art\u0131\u015f.<\/p>\n<p>\u0130\u015fte son d\u00f6n\u00fcm noktalar\u0131n\u0131n fiyat \u00fczerindeki etkileri:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Etkisi<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>20 A\u011fu 2025<\/td>\n<td>FDA sNDA Kabul\u00fc<\/td>\n<td>+%4,6<\/td>\n<td>2 g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>9 Tem 2025<\/td>\n<td>Bivamelagon Faz 2 Sonu\u00e7lar\u0131<\/td>\n<td>+%25,4<\/td>\n<td>1 hafta<\/td>\n<\/tr>\n<tr>\n<td>10 Tem 2025<\/td>\n<td>175 Milyon $ Halka Arz<\/td>\n<td>-%3,2<\/td>\n<td>1 g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>2025 2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>Ticari Gelir \u00dcst\u00fc<\/td>\n<td>+%8,1<\/td>\n<td>3 g\u00fcn<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ders? FDA kataliz\u00f6rleri an\u0131nda momentum yarat\u0131rken, seyrelme olaylar\u0131 k\u0131sa vadeli d\u00fc\u015f\u00fc\u015flere neden olur ve genellikle al\u0131m f\u0131rsatlar\u0131 sunar.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: 55 $&#8217;dan 100+ $&#8217;a<\/h3>\n<p>Rhythm hisseleri, <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RYTM\/chart\/\">MarketBeat verilerine<\/a> g\u00f6re y\u0131lba\u015f\u0131ndan bu yana inan\u0131lmaz bir <strong>%82,74<\/strong> getiri sa\u011flad\u0131. \u0130\u015fte ayl\u0131k da\u011f\u0131l\u0131m:<\/p>\n<p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 55 $ (k\u0131\u015f konsolidasyon sonras\u0131)<br \/> <strong>May\u0131s 2025<\/strong>: 75-80 $ (Faz 2 deneme beklentisi)<br \/> <strong>Temmuz 2025<\/strong>: 85+ $ (deneme sonu\u00e7lar\u0131 ve halka arz)<br \/> <strong>A\u011fustos 2025<\/strong>: 99-103 $ (FDA kataliz\u00f6r zirvesi)<\/p>\n<p>Bu y\u00fckseli\u015fi tetikleyenler? Bivamelagon ile %9,3&#8217;e varan BMI d\u00fc\u015f\u00fc\u015f\u00fc g\u00f6steren patlay\u0131c\u0131 klinik deneme sonu\u00e7lar\u0131 ve Aral\u0131k 2025 i\u00e7in kritik FDA \u00f6ncelikli inceleme atamas\u0131.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli (\u00d6n\u00fcm\u00fczdeki 3-6 Ay)<\/h3>\n<p>20 Aral\u0131k 2025 PDUFA tarihi yakla\u015f\u0131rken, analistler onay verilirse RYTM&#8217;nin <strong>110-120 $<\/strong> aral\u0131\u011f\u0131na ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor. Mevcut 12 ayl\u0131k ortalama hedef fiyat <a href=\"https:\/\/valueinvesting.io\/RYTM\/estimates\">18 analiste g\u00f6re<\/a> <strong>80,83 $<\/strong>, ancak bu son momentum g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda temkinli g\u00f6r\u00fcn\u00fcyor.<\/p>\n<p><strong>Karar<\/strong>: G\u00dc\u00c7L\u00dc AL &#8211; FDA kataliz\u00f6r penceresi ola\u011fan\u00fcst\u00fc yukar\u0131 potansiyel yarat\u0131yor.<\/p>\n<h3>Orta Vadeli (2026)<\/h3>\n<p>Ticari geni\u015flemenin h\u0131zlanmas\u0131yla <strong>130-150 $<\/strong> aral\u0131\u011f\u0131 bekleniyor. Gelirin gelecek y\u0131l %65,62 art\u0131\u015fla 310 milyon $&#8217;a ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor ve bivamelagon ba\u015far\u0131l\u0131 \u015fekilde Faz III&#8217;e ge\u00e7erse de\u011ferleme \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fleyebilir.<\/p>\n<h3>Uzun Vadeli (2028-2030)<\/h3>\n<p>2028 itibar\u0131yla birden fazla onayl\u0131 endikasyon ve uluslararas\u0131 geni\u015fleme ile <strong>200-250 $<\/strong> ula\u015f\u0131labilir g\u00f6r\u00fcn\u00fcyor. 2030&#8217;da Rhythm MC4R tedavi \u015firketi olarak hakim konuma gelirse, nadir obezite hastal\u0131klar\u0131ndaki adreslenebilir pazar g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda <strong>300+ $<\/strong> ger\u00e7ek\u00e7i.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<h3>Y\u00fcksek Etkili Riskler<\/h3>\n<p><strong>D\u00fczenleyici Reddetme<\/strong>: Aral\u0131k FDA karar\u0131 ikili\u2014onay hisseleri u\u00e7urur, reddedilirse %30-50 d\u00fc\u015f\u00fc\u015f olabilir.<\/p>\n<p><strong>Klinik Geri Ad\u0131mlar<\/strong>: Bivamelagon i\u00e7in Faz III denemeleri yak\u0131nda ba\u015flayacak\u2014herhangi bir g\u00fcvenlik sorunu y\u0131k\u0131c\u0131 olur.<\/p>\n<p><strong>Nakit Yak\u0131m\u0131<\/strong>: 175 milyon $ toplamas\u0131na ra\u011fmen Rhythm y\u0131lda ~188 milyon $ yak\u0131yor. 12-18 ay i\u00e7inde ek finansman gerekecek.<\/p>\n<h3>Orta Riskler<\/h3>\n<p><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri rakip MC4R agonistleri geli\u015ftiriyor.<\/p>\n<p><strong>Fiyat Bask\u0131s\u0131<\/strong>: \u00d6deme yapanlar nadir hastal\u0131k tedavilerinde y\u00fcksek fiyatlara kar\u015f\u0131 diren\u00e7 g\u00f6sterebilir.<\/p>\n<h2>\ud83d\udfe2 Pozitif Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanma Nedenleri<\/h2>\n<h3>Klinik Ba\u015far\u0131lar<\/h3>\n<p><a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/rhythm-stock-climbs-encouraging-obesity-data\/\">Faz 2 bivamelagon verileri<\/a> ola\u011fan\u00fcst\u00fcyd\u00fc\u2014plasebonun %2,2 art\u0131\u015f\u0131na kar\u015f\u0131l\u0131k %9,3 BMI d\u00fc\u015f\u00fc\u015f\u00fc. Bu marjinal bir iyile\u015fme de\u011fil; potansiyel olarak uygulamay\u0131 de\u011fi\u015ftiren bir geli\u015fme.<\/p>\n<h3>Pazar Tekeli<\/h3>\n<p>Orphan ila\u00e7 stat\u00fcs\u00fc 7 y\u0131l pazar tekel hakk\u0131 sa\u011fl\u0131yor\u2014b\u00fcy\u00fck bir rekabet engeli.<\/p>\n<h3>Gelir H\u0131zlanmas\u0131<\/h3>\n<p>2025 2. \u00e7eyrek %43,84 gelir art\u0131\u015f\u0131yla y\u0131ll\u0131k 187 milyon $&#8217;a ula\u015ft\u0131. B\u00fcy\u00fcme e\u011frisi dik ve s\u00fcrd\u00fcr\u00fclebilir.<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in \u0130\u015flem Plan\u0131<\/h2>\n<p><strong>Bug\u00fcn\u00fcn Ger\u00e7e\u011fi<\/strong>: RYTM ilgin\u00e7 bir noktada\u2014son zirvelerin hemen alt\u0131nda ama b\u00fcy\u00fck FDA kataliz\u00f6r\u00fc yakla\u015fmakta.<\/p>\n<p><strong>\u015eimdi Ne Yapmal\u0131<\/strong>:<\/p>\n<ol>\n<li><strong>Kademeli Al\u0131m Yap\u0131n<\/strong>: Hepsini birden almay\u0131n. \u015eimdi %25, 90 $&#8217;a d\u00fc\u015ferse %25, \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131ndan sonra %50 al\u0131n<\/li>\n<li><strong>4 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: \u00dc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131 ticari momentumun devam edip etmedi\u011fini g\u00f6sterecek<\/li>\n<li><strong>Aral\u0131k Volatilitesine Haz\u0131rlan\u0131n<\/strong>: FDA kararlar\u0131 a\u015f\u0131r\u0131 hareketler yarat\u0131r\u2014hem kar alma hem ortalama maliyet d\u00fc\u015f\u00fcrme planlar\u0131n\u0131z haz\u0131r olsun<\/li>\n<\/ol>\n<p><strong>Esprili Yakla\u015f\u0131m<\/strong>: &#8220;RYTM ticareti izlemek bir t\u0131bbi drama izlemek gibi\u2014her b\u00f6l\u00fcm hastay\u0131 kurtaran ya da acil ameliyat gerektiren bir gerilimle biter. Patlam\u0131\u015f m\u0131s\u0131r\u0131n\u0131z\u0131 ve risk y\u00f6netiminizi getirin!&#8221;<\/p>\n<h2>\u2705 Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>NASDAQ hisselerini sunan ve makul komisyon yap\u0131s\u0131na sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014biyotek volatil olabilir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;RYTM&#8221; Aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n\u2014volatil hisselerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Hisse miktar\u0131 ve emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option RYTM Yat\u0131r\u0131m\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor<\/h2>\n<p>Rhythm hikayesine ilgi duyan ama volatiliteden \u00e7ekinen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option m\u00fckemmel bir deneme alan\u0131 sunuyor. <strong>sadece 5 $ minimum depozito<\/strong> ile portf\u00f6y\u00fcn\u00fcz\u00fc a\u015f\u0131r\u0131 riske atmadan k\u00fc\u00e7\u00fck pozisyon alabilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde, biyotek hisselerinde saatlerin \u00f6nemli oldu\u011fu kritik haberler kar\u015f\u0131s\u0131nda h\u0131zl\u0131 tepki verebilirsiniz.<\/p>\n<p>Pocket Option&#8217;\u0131 RYTM ticareti i\u00e7in farkl\u0131 k\u0131lanlar:<\/p>\n<ul>\n<li><strong>Par\u00e7al\u0131 Hisseler<\/strong>: \u0130lk pozisyonunuz i\u00e7in 99 $ \u00e7ok y\u00fcksekse k\u0131smi hisse alabilirsiniz<\/li>\n<li><strong>Ger\u00e7ek Zamanl\u0131 Uyar\u0131lar<\/strong>: FDA haberleri ve kazan\u00e7lar hakk\u0131nda an\u0131nda bildirim al\u0131n<\/li>\n<li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong>: FDA y\u00fckseli\u015finden kar etti\u011finizde paran\u0131za kripto, e-c\u00fczdan veya geleneksel bankac\u0131l\u0131k yoluyla eri\u015fin<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Rhythm Pharmaceuticals: Nadir Hastal\u0131k Lideri<\/h2>\n<p>Rhythm, klinik a\u015fama \u015firketinden genetik obezite tedavilerinde ticari liderli\u011fe d\u00f6n\u00fc\u015ft\u00fc. Bayrak gemisi ilac\u0131 IMCIVREE\u00ae, POMC eksikli\u011fi ve Bardet-Biedl sendromu gibi \u00e7o\u011fu doktorun hi\u00e7 g\u00f6rmedi\u011fi \u00e7ok nadir hastal\u0131klar\u0131 tedavi ediyor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Bilgi<\/strong>: Rhythm&#8217;in ara\u015ft\u0131rmas\u0131 o kadar \u00f6zelle\u015fmi\u015f ki, d\u00fcnya \u00e7ap\u0131nda tedavilerine uygun sadece 500&#8217;\u00fcn biraz \u00fczerinde hasta i\u00e7in k\u00fcresel bir kay\u0131t tutuyorlar. Bu kitlesel pazar ila\u00e7lar\u0131 de\u011fil\u2014en \u00f6zel hassas t\u0131p \u00f6rne\u011fi.<\/p>\n<p>\u015eirketin yak\u0131n zamanda ger\u00e7ekle\u015ftirdi\u011fi <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/07\/10\/3113078\/0\/en\/Rhythm-Pharmaceuticals-Inc-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html\">175 milyon $&#8217;l\u0131k halka arz<\/a> 85 $ hisse fiyat\u0131yla g\u00fc\u00e7l\u00fc kurumsal g\u00fcveni g\u00f6sterdi; Morgan Stanley ve BofA Securities gibi b\u00fcy\u00fck bankalar arz\u0131 y\u00f6netti.<\/p>\n"},"faq":[{"question":"Rhythm Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, RYTM sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak hisse sat\u0131n al\u0131n ve i\u015flemi onaylay\u0131n."},{"question":"RYTM hisselerinin fiyat\u0131 ne kadar?","answer":"28 A\u011fustos 2025 itibar\u0131yla RYTM hisseleri 99,20 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"FDA kararlar\u0131 RYTM hisselerini nas\u0131l etkiler?","answer":"FDA onaylar\u0131 genellikle hisse fiyat\u0131nda ani y\u00fckseli\u015flere neden olurken, reddedilme durumunda fiyatlar %30-50 aras\u0131nda d\u00fc\u015febilir."},{"question":"RYTM hisseleri i\u00e7in k\u0131sa vadeli fiyat tahmini nedir?","answer":"Aral\u0131k 2025 FDA onay\u0131 durumunda fiyat\u0131n 110-120 $ aral\u0131\u011f\u0131na \u00e7\u0131kmas\u0131 beklenmektedir."},{"question":"RYTM hisseleri yat\u0131r\u0131m\u0131nda riskler nelerdir?","answer":"D\u00fczenleyici reddetme, klinik deneme sorunlar\u0131, y\u00fcksek nakit yak\u0131m\u0131, rekabet ve fiyat bask\u0131s\u0131 ba\u015fl\u0131ca risklerdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Rhythm Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, RYTM sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak hisse sat\u0131n al\u0131n ve i\u015flemi onaylay\u0131n."},{"question":"RYTM hisselerinin fiyat\u0131 ne kadar?","answer":"28 A\u011fustos 2025 itibar\u0131yla RYTM hisseleri 99,20 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"FDA kararlar\u0131 RYTM hisselerini nas\u0131l etkiler?","answer":"FDA onaylar\u0131 genellikle hisse fiyat\u0131nda ani y\u00fckseli\u015flere neden olurken, reddedilme durumunda fiyatlar %30-50 aras\u0131nda d\u00fc\u015febilir."},{"question":"RYTM hisseleri i\u00e7in k\u0131sa vadeli fiyat tahmini nedir?","answer":"Aral\u0131k 2025 FDA onay\u0131 durumunda fiyat\u0131n 110-120 $ aral\u0131\u011f\u0131na \u00e7\u0131kmas\u0131 beklenmektedir."},{"question":"RYTM hisseleri yat\u0131r\u0131m\u0131nda riskler nelerdir?","answer":"D\u00fczenleyici reddetme, klinik deneme sorunlar\u0131, y\u00fcksek nakit yak\u0131m\u0131, rekabet ve fiyat bask\u0131s\u0131 ba\u015fl\u0131ca risklerdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T11:45:17+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T11:45:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\",\"name\":\"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-28T11:45:17+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T11:45:17+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T11:45:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/","name":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-28T11:45:17+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Rhythm Pharmaceuticals, Inc. (RYTM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rhythm Pharmaceuticals, Inc. (RYTM) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354212,"slug":"how-to-buy-rhythm-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rhythm Pharmaceuticals, Inc. (RYTM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rhythm Pharmaceuticals, Inc. (RYTM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":354208,"slug":"how-to-buy-rhythm-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Rhythm Pharmaceuticals, Inc. (RYTM) - Investimento em a\u00e7\u00f5es da Rhythm Pharmaceuticals, Inc. (RYTM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-rhythm-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354209"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354209\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}